Validation of a Novel Screening Test for Maternal Insulin Resistance

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 15, 2017

Primary Completion Date

July 15, 2019

Study Completion Date

July 15, 2019

Conditions
Insulin Resistance, Diabetes
Interventions
DIAGNOSTIC_TEST

Quantose IR and Quantose IGT analysis

Testing using Quantose IR and Quantose IGT: The blood draws will be timed to coincide with clinically indicated blood tests as much as possible (e.g. first visit labs, aneuploidy screening, gestational diabetes screening).

DIAGNOSTIC_TEST

HOMA IR the standard testing for insulin resistance

Testing using HOMA IR: Investigators will be measuring fasting insulin and glucose levels (last meal more than 8hrs before testing i.e. overnight fasting) from EDTA-plasma samples. After collection, the samples will be spun and plasma obtained. Samples will be stored until testing. The investigators will be using the following computation to calculate HOMA.

Trial Locations (1)

77555

Ashley Salazar, Galveston

All Listed Sponsors
lead

The University of Texas Medical Branch, Galveston

OTHER

NCT03388697 - Validation of a Novel Screening Test for Maternal Insulin Resistance | Biotech Hunter | Biotech Hunter